Desenvolvimento e validação de método analítico para quantificação do fármaco bevacizumabe por cromatografia a líquido de alta eficiência

Abstract

Y.In this study, an analytical method was developed and validated for quantitation of the drug bevacizumab (Avastin® ) by high performance liquid chromatography (HPLC). The HPLC column was a BioSuite 250® HR SEC, 300 x 7.8 mm x 5 µm (Waters, USA). The mobile phase consisted of phosphate buffered saline (PBS). The results revealed that the method was specific, precise, accurate, robust and linear (r2 = 0.998) from 5 to 75 µg mL-1 . Therefore, this method can be used in drug release studies or in quality control ampoules of the drug.